Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-28 Exercise |
2024-02-29 4:29 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA |
67,400 | $0 | 255,742 (Direct) |
View |
| 2024-02-28 Tax Withholding |
2024-02-29 4:29 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA |
24,353 | $2.62 | 255,742 (Direct) |
View |
| 2024-02-08 Option Award |
2024-02-12 4:15 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA |
407,620 | $0 | 407,620 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-01 4:51 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA |
52,886 | $0 | 181,825 (Direct) |
View |
| 2023-02-28 Tax Withholding |
2023-03-01 4:51 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA |
19,118 | $2.17 | 181,825 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 5:00 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA |
393,080 | $0 | 393,080 (Direct) |
View |
| 2022-02-28 Exercise |
2022-02-28 7:15 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA |
36,628 | $0 | 118,273 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-02-28 7:15 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA |
13,241 | $2.85 | 118,273 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:06 pm |
N/A 2032-02-10 |
LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA |
330,680 | $0 | 330,680 (Direct) |
View |
Ownership |
2021-10-01 4:05 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA |
0 | $0 | 409,675 (Direct) |
View |